The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of pelcitoclax (APG-1252) in combination with paclitaxel in patients (pts) with relapsed/refractory small-cell lung cancer (R/R SCLC).
 
Angel Qin
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Takeda (Inst); Xencor (Inst)
 
Gregory Peter Kalemkerian
Consulting or Advisory Role - BioMed Valley Discoveries (I); Synlogic (I); Takeda (I)
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); Cullinan Oncology (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Merck (Inst); Takeda (Inst)
 
Nisha Anjali Mohindra
Consulting or Advisory Role - AstraZeneca/MedImmune; G1 Therapeutics
Research Funding - Pfizer (Inst)
 
Jyoti D. Patel
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech; Lilly; Takeda Science Foundation
Research Funding - Bristol-Myers Squibb (Inst)
 
Christos Stelios Karapetis
No Relationships to Disclose
 
Jennifer W Carlisle
Research Funding - AstraZeneca (Inst)
 
Jacob Sands
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo/UCB Japan; Jazz Pharmaceuticals; Lilly; Medtronic; Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Alexander I. Spira
Leadership - Next Oncology (Inst)
Stock and Other Ownership Interests - Lilly
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Janssen Oncology; Merck; Novartis; Takeda
Consulting or Advisory Role - Amgen; Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca; Gritstone Bio; Gritstone Bio; incyte; Janssen Research & Development; Jazz Pharmaceuticals; Merck (Inst); Mersana; Mirati Therapeutics; Novartis; Takeda
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); ADC Therapeutics (Inst); Amgen (Inst); Arch Therapeutics (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Gritstone Bio (Inst); Ignyta (Inst); Incyte (Inst); Janssen Oncology (Inst); LAM Therapeutics; LAM Therapeutics (Inst); Loxo (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); mersana (Inst); Mirati Therapeutics (Inst); Newlink Genetics (Inst); Novartis (Inst); Plexxikon (Inst); Roche (Inst); Rubius Therapeutics (Inst); Synthekine (Inst); Takeda (Inst); Trovagene (Inst)
 
Bo Gao
Consulting or Advisory Role - BeiGene; MSD
 
Harshad Amin
No Relationships to Disclose
 
Bishnuhari Paudyal
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
 
Genevieve Frank
Employment - Ascentage Pharma Group
 
Xuemei Sun
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
 
Yang Xu
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
 
Cunlin Wang
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
 
Tommy Fu
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
 
Robert Winkler
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
 
ZHIYAN LIANG
Employment - Ascentage Pharma Group
Stock and Other Ownership Interests - Ascentage Pharma Group
 
Dajun Yang
Employment - Ascentage Pharma Group; Ascentage Pharma Group (I)
Leadership - Ascentage Pharma Group; Ascentage Pharma Group (I)
Stock and Other Ownership Interests - Ascentage Pharma Group; Ascentage Pharma Group (I)
Research Funding - Ascentage Pharma Group (Inst)
Patents, Royalties, Other Intellectual Property - Ascentage Pharma Group; Ascentage Pharma Group (I); Ascentage Pharma Group (Inst)
 
Yifan Zhai
Employment - Ascentage Pharma Group; Ascentage Pharma Group (I)
Leadership - Ascentage Pharma Group; Ascentage Pharma Group (I)
Stock and Other Ownership Interests - Ascentage Pharma Group; Ascentage Pharma Group (I)
Research Funding - Ascentage Pharma Group (Inst)
Patents, Royalties, Other Intellectual Property - Ascentage Pharma Group; Ascentage Pharma Group (I); Ascentage Pharma Group (Inst)